Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:05 PM
Ignite Modification Date:
2025-12-25 @ 2:06 PM
NCT ID:
NCT03101566
Group ID:
EG000
Title:
Gemcitabine + Cisplatin + Nivolumab
Description:
Gemcitabine1000 mg/m2 IV and Cisplatin 25 mg/m2 IV on days 1 and 8 every 3 weeks + Nivolumab 360 mg IV on day 1 every 3 weeks for up to 8, 3-week cycles. Followed by Nivolumab alone at 240 mg IV every 2 weeks. Total duration no longer than 2 years of study treatment.
Deaths Number Affected:
22
Deaths Number At Risk:
None
Serious Number Affected:
25
Serious Number At Risk:
35
Other Number Affected:
34
Other Number At Risk:
35
Study:
NCT03101566
Results Section:
NCT03101566
Adverse Events Module:
NCT03101566